A 24-year-old Indian woman with known sickle cell disease (HbSS genotype) presents with sudden onset of severe chest pain, dyspnea, and fever. Chest X-ray shows a new infiltrate in the right lower lobe. Her oxygen saturation is 88% on room air, hemoglobin is 6.8 g/dL (baseline 7.5 g/dL), and reticulocyte count is 12%. Blood cultures are pending. Which of the following is the most likely diagnosis?

Explanation

## Acute Chest Syndrome (ACS) in Sickle Cell Disease ### Definition and Epidemiology **Key Point:** Acute chest syndrome is a life-threatening pulmonary complication of sickle cell disease, defined by the presence of a new pulmonary infiltrate on imaging plus respiratory symptoms (chest pain, dyspnea, cough, fever). It is the second leading cause of death in sickle cell disease after stroke. ### Pathophysiology of ACS ```mermaid flowchart TD A[Sickle Cell Disease]:::outcome --> B[Vaso-occlusion in Bone Marrow]:::outcome B --> C[Bone Marrow Infarction]:::outcome C --> D[Fat Embolism from Necrotic Marrow]:::action D --> E[Pulmonary Vaso-occlusion]:::action E --> F[Acute Chest Syndrome]:::urgent A --> G[Pulmonary Vaso-occlusion]:::action G --> F A --> H[Infection Predisposition]:::action H --> I[Pneumonia as Trigger]:::outcome I --> F ``` ### Mechanisms of ACS | Mechanism | Pathophysiology | Frequency | | --- | --- | --- | | **Pulmonary vaso-occlusion** | Sickling in pulmonary vessels → hypoxia, infarction, inflammation | ~50% | | **Fat embolism** | Bone marrow infarction → release of lipid-rich marrow contents into circulation → pulmonary embolism | ~50% | | **Infection (secondary trigger)** | Functional asplenia → increased susceptibility to encapsulated organisms (Streptococcus pneumoniae, Haemophilus influenzae) | Often concurrent | | **In situ thrombosis** | Endothelial damage from sickling → platelet activation and microthrombi | Contributing factor | ### Clinical Features of ACS **High-Yield:** The classic triad is: 1. **New pulmonary infiltrate** on CXR (often in lower lobes) 2. **Respiratory symptoms** (chest pain, dyspnea, cough) 3. **Systemic symptoms** (fever, malaise) This patient has all three: new RLL infiltrate, dyspnea, chest pain, and fever. ### Laboratory Findings in ACS - **Hemoglobin drop**: Acute anemia (6.8 g/dL vs. baseline 7.5 g/dL) from ongoing hemolysis and sequestration - **Elevated reticulocyte count**: 12% reflects compensatory erythropoiesis - **Hypoxemia**: PaO~2~ typically < 80 mmHg on room air - **Leukocytosis**: Often present due to infection or inflammatory response **Clinical Pearl:** The acute drop in hemoglobin (0.7 g/dL) is significant and suggests acute sequestration or hemolysis triggered by the ACS event itself. ### Differential Diagnosis in ACS | Diagnosis | Key Distinguishing Feature | | --- | --- | | **Acute Chest Syndrome** | New infiltrate + respiratory symptoms in sickle cell patient; vaso-occlusion is primary mechanism | | **Pneumonia** | May coexist with ACS; culture-positive; but functional asplenia makes infection a trigger, not sole cause | | **PE** | Rare in sickle cell without immobility; ACS is far more common | | **MI** | Coronary vasculitis is rare; ACS causes hypoxemia and secondary cardiac stress | **Warning:** Do not confuse ACS with simple pneumonia. While infection can trigger ACS, the underlying mechanism is vaso-occlusion and fat embolism, not infection alone.